TAU Ventures — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Biotia develops infectious disease diagnostics using clinical metagenomic next-generation sequencing paired with artificial intelligence, offering diagnostic tests and genomics software for patients, providers, and health systems managing challenging infections.
AI & Machine LearningBiotechDigital Health
Chris Mason(Founder)inNiamh O'Hara(Founder & CEO)inNiamh B. O'Hara(Founder)in
Co-investorsCloquet Capital Partners, LLCConvergent VenturesDigitalDx VenturesEverywhere VenturesHyperplane Venture CapitalMEDA Angels+11 more
Senior healthcare solutions in Malaysia
Co-investorsGobi PartnersCity LightFika VenturesGlobal Founders CapitalMucker CapitalQuiet Capital+1 more
Ghost builds AI agents that perform security operations and incident response work autonomously within enterprise environments, designed to investigate, contain, and resolve security events while maintaining full auditability and human oversight.
AI & Machine LearningCybersecurityEnterprise Software
Co-investorsIn-Q-TelLytical VenturesRitual Capital468 CapitalDnx VenturesMunich Re Ventures+1 more
Untapped is a recruiting platform that connects job candidates with tech and finance companies, offering a more equitable hiring process by looking beyond traditional filters like school and work experience.
HR TechSaaSWest Hollywood, US
Co-investorsAlumni VenturesEvolution VC PartnersOwl VenturesCameron VenturesMensch Capital PartnersRethink Impact+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



















